Article Information
History
- May 15, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Anton De Spiegeleer1,2,3,*,
- Antoon Bronselaer4,*,
- James T Teo5,
- Geert Byttebier6,
- Guy De Tré4,
- Luc Belmans7,
- Richard Dobson8,
- Evelien Wynendaele1,
- Christophe Van De Wiele9,
- Filip Vandaele10,
- Diemer Van Dijck11,
- Dan Bean8,
- David Fedson12 and
- Bart De Spiegeleer1,**
- 1Drug Quality and Registration group, Faculty of Pharmaceutical Sciences, Ghent University, Belgium
- 2Department of Geriatrics, Faculty of Medicine and Health Sciences, Ghent University Hospital, Belgium
- 3Unit for Molecular Immunology and Inflammation, VIB-Center for Inflammation Research, Belgium
- 4DDCM lab, Department of Telecommunications and Information Processing, Faculty of Engineering and Architecture, Ghent University, Belgium
- 5Department of Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
- 6Bioconstat BV, Ghent, Belgium
- 7Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University Hospital, Belgium
- 8Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK
- 9Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University Hospital, Belgium
- 10VZW Zorg-Saam Zusters Kindsheid Jesu, Ghent, Belgium
- 11Corilus Health IT Center, Ghent, Belgium
- 12Sergy Haut, France
- ↵**Corresponding author; e-mail: bart.despiegeleer{at}ugent.be
↵* Equally contributed as first authors
Posted May 15, 2020.
The effects of ARBs, ACEIs and statins on clinical outcomes of COVID-19 infection among nursing home residents
